Clinical Trials Browser

Phase 1/2 × Melanoma × Carmustine × Clear all

NCT06626516 2025-11-28

Tebentafusp-tebn With LDT in Metastatic UM

Phase 1/2 Recruiting

Uveal Melanoma, Melanoma